These findings demonstrate that lncRNA GHRLOS exerts tumor inhibitory activity in the development of NSCLC, suggesting that overexpression of lncRNA GHRLOS could be used for treatment in patients with NSCLC. Here, GHRLOS is linked to neoplasm.